Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Malaria is amongst the biggest killers of children in the developing world with almost half a million deaths annually.

A high-efficacy malaria vaccine is urgently required to reduce the unacceptable burden of malaria mortality and morbidity in Africa, and to assist efforts towards malaria elimination.

We are developing the first multi-stage vaccine for malaria designed to target all stages of the parasite’s life-cycle which will be tested in clinical trials in Africa.